New scan could spot dangerous prostate cancer earlier, reduce unnecessary biopsies
NCT ID NCT03471650
First seen Apr 11, 2026 · Last updated May 20, 2026 · Updated 10 times
Summary
This study tests a special PET scan (18F-DCFPyL) that targets prostate cancer cells to see if it can better detect aggressive prostate cancer in men with elevated PSA levels. About 150 men with PSA between 2-10 who have not had a prior prostate biopsy will receive the scan before their standard biopsy. The goal is to see if this scan is more accurate than PSA alone at finding cancers that need treatment, potentially reducing unnecessary biopsies and over-treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
SKCCC
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.